Two Sigma Securities, LLC Seelos Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.16 - $1.64 $2,694 - $27,614	-16,838 Reduced 53.76%	14,483 $2,000
Q2 2023 Aug 14, 2023	BUY	$0.66 - $1.22 $20,671 - $38,211	31,321 New	31,321 $37,000
Q4 2020 Feb 16, 2021	SELL	$0.74 - $2.01 $19,171 - $52,073	-25,907 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.6 - $1.25 $15,544 - $32,383	25,907 New	25,907 $24,000
Q2 2020 Aug 14, 2020	SELL	$0.42 - $1.51 $11,945 - $42,947	-28,442 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.47 - $1.56 $7,002 - $23,240	14,898 Added 110.0%	28,442 $14,000
Q4 2019 Feb 14, 2020	SELL	$0.72 - $1.52 $6,732 - $14,212	-9,350 Reduced 40.84%	13,544 $18,000
Q3 2019 Nov 14, 2019	BUY	$0.92 - $2.15 $21,062 - $49,222	22,894 New	22,894 $21,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $41.6M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.